Thompson Coburn is pleased to announce that Dr. Elizabeth “Betsy” Haanes has joined the firm as a partner in our Washington, D.C., office. An accomplished scientist with a Ph.D. in microbiology, Dr. Haanes will practice in the firm’s Intellectual Property group. She previously served as a director at Sterne Kessler Goldstein & Fox.
Dr. Haanes advises innovator biotechnology and pharmaceutical companies on best practices for the worldwide protection of their intellectual property. In all aspects of her practice, she focuses on creating innovative, long-term legal strategies that integrate seamlessly into her clients' technological and business objectives.
An experienced legal counselor, Dr. Haanes advises clients on the creation and management of high-value patent portfolios, freedom-to-operate and patentability issues, validity and infringement issues, and due diligence investigations in connection with acquisitions and investments.
Her clients represent a diverse body of entities in technology areas such as vaccines, infectious diseases, medical diagnostics, biomarkers, personalized medicine, therapeutic antibodies, therapeutic nucleic acids, genomics, proteomics, and gene therapy.
Before practicing law, Dr. Haanes performed infectious disease and vaccine research in academia and industry. She published widely in the areas of microbial pathogenesis, molecular virology, and vaccines, and is an inventor on numerous patents and published applications relating to recombinant vaccines.
Dr. Haanes earned her law degree from the University of Colorado. She obtained her Ph.D. from the University of Minnesota and a B.S. in biology from the University of Michigan.